Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
10/21/2010 | WO2010120002A1 Black-lip pearl oyster egg extract, and method for assessing the productive effort of a black-lip pearl oyster using a black-lip pearl oyster egg extract-specific polyclonal antibody |
10/21/2010 | WO2010119769A1 Method for evaluation of chronic stress |
10/21/2010 | WO2010119704A1 Antibodies that specifically bind to a beta oligomers and use thereof |
10/21/2010 | WO2010119693A1 Method of screening for insulin secretion-potentiating agents |
10/21/2010 | WO2010119691A1 Diagnosis and treatment of cancer using anti-tmprss11e antibody |
10/21/2010 | WO2010119501A1 Bodily fluid component analyzer |
10/21/2010 | WO2010119495A1 Method and apparatus for measuring concentration of biological component |
10/21/2010 | WO2010119403A2 Cellular electric stimulation mediated by piezoelectric nanotubes |
10/21/2010 | WO2010119380A1 Microfluidic device comprising sensor |
10/21/2010 | WO2010119362A1 Protein-based methods and compositions for the diagnosis of colorectal adenocarcinoma |
10/21/2010 | WO2010119341A1 On-board control detection |
10/21/2010 | WO2010119307A1 Method for stimulating antigen-specific t cell responses using accelerated co-cultured dendritic cells |
10/21/2010 | WO2010119295A1 Biomarkers |
10/21/2010 | WO2010119286A1 Alzheimer's disease |
10/21/2010 | WO2010119261A1 Method for quantifying modified peptides |
10/21/2010 | WO2010119164A1 Device and method for measuring the quantity of a flowing liquid |
10/21/2010 | WO2010119162A1 Method for detecting copper complexes of chlorophyll in vegetable oils |
10/21/2010 | WO2010119069A1 Selective ion transport device |
10/21/2010 | WO2010119061A1 Method for determining the cbl-b expression |
10/21/2010 | WO2010119033A1 Method for stimulating antigen-specific t cell responses using accelerated co-cultured dendritic cells |
10/21/2010 | WO2010119003A1 Biomarker for monitoring patients |
10/21/2010 | WO2010119001A1 Prostate cancer cell lines and their use in screening method |
10/21/2010 | WO2010118991A1 Methods for selecting oocytes and competent embryos with high potential for pregnancy outcome |
10/21/2010 | WO2010118890A1 B-lymphocyte targeting agents for use in a method for the treatment of a disease |
10/21/2010 | WO2010118861A1 Homogeneous agglutination immunoassay method and kit for such method |
10/21/2010 | WO2010118855A1 Risk assessment for antibiotics treatment in patients suffering from primary non-infectious disease by determining the level of procalcitonin |
10/21/2010 | WO2010118754A1 Selective ion transport device |
10/21/2010 | WO2010118525A1 Signature of secreted protein isoforms specific to ovarian cancer |
10/21/2010 | WO2010118524A1 Sensitizing agents for cancer therapy, methods of use and methods for the identification thereof |
10/21/2010 | WO2010118520A1 Process for tumour characteristic and marker set identification, tumour classification and marker sets for cancer |
10/21/2010 | WO2010099543A3 Compositions and methods for detecting oral neoplasm |
10/21/2010 | WO2010099328A3 Spatially-selective reflector structures, reflector disks, and systems and methods for use thereof |
10/21/2010 | WO2010099137A3 In situ methods for monitoring the emt status of tumor cells in vivo |
10/21/2010 | WO2010097553A3 Method for diagnosing vasculitis |
10/21/2010 | WO2010096117A3 Methods of treating psychosis and schizophrenia based on polymorphisms in the erbb4 gene |
10/21/2010 | WO2010094734A3 Methods for identifying and compounds useful for the diagnosis and treatment of diseases involving inflammation |
10/21/2010 | WO2010092488A3 Method for evaluating risk in multiple sclerosis |
10/21/2010 | WO2010091692A3 Constitutively active mutants of gpcr 88 and uses thereof |
10/21/2010 | WO2010087594A3 Cd93 or use of soluble fragment thereof |
10/21/2010 | WO2010083484A3 System and method for characterization of oral, systemic and mucosal tissue utilizing raman spectroscopy |
10/21/2010 | WO2010082790A3 Electroresponsive device for extending the life of biosensors, and a biosensor employing the same |
10/21/2010 | WO2010079919A3 Method for screening matrix metalloproteinase |
10/21/2010 | WO2010078511A3 Detection of oligosaccharides |
10/21/2010 | WO2010067358A3 Methods and kits for direct detection and susceptibility profiling of beta-lactam resistant bacteria |
10/21/2010 | WO2010065929A9 Method for diagnosing allergic reactions |
10/21/2010 | WO2010062116A3 High resolution surface plasmon resonance sensor and sensor system thereof |
10/21/2010 | WO2010057943A3 Analysis system for fuel analysis |
10/21/2010 | WO2010053980A3 Dna integrity assay (dia) for cancer diagnostics, using confocal fluorescence spectroscopy |
10/21/2010 | WO2010042890A3 Polypeptides that bind trail-ri and trail-r2 |
10/21/2010 | WO2010007391A9 Hexacyanoferrate modified electrode |
10/21/2010 | WO2009149087A9 Method for distinguishing between kidney dysfunctions |
10/21/2010 | WO2009120249A8 Detection of head and neck cancer using hypermethylated gene detection |
10/21/2010 | US20100269180 Methods, compositions and transgenic models related to the interaction of t-cadherin and adiponectin |
10/21/2010 | US20100268480 Method and system for measuring emission and quantifying emission source |
10/21/2010 | US20100268477 Systems and Methods for Calibrating Physiological Characteristic Sensors |
10/21/2010 | US20100268474 Methods, systems and computer program products for predicting responsiveness to a pharmaceutical therapy for obesity or evaluating investigational pharmaceutical agents |
10/21/2010 | US20100268473 Methods, devices, and compositions for the highly-sensitive detection and identification of diverse molecular entities |
10/21/2010 | US20100268472 Determination of single peak melting temperature by pcr analogy and double sigmoid equation |
10/21/2010 | US20100267937 Cyanine Dye Labelling Reagents |
10/21/2010 | US20100267930 SLO2 and SLO4, Novel Potassium Channel Proteins from Human Brain |
10/21/2010 | US20100267842 Emulsions of Perfluorocarbons |
10/21/2010 | US20100267816 Human anti-amyloid beta peptide antibody and fragment of said antibody |
10/21/2010 | US20100267804 Differential expression of micrornas in nonfailing versus failing human hearts |
10/21/2010 | US20100267771 Automated immunossay apparatus with flexible pick-up arm |
10/21/2010 | US20100267737 4-phenylpiperazine derivatives with functionalized linkers as dopamine d3 receptor selective ligands and methods of use |
10/21/2010 | US20100267646 Trophic Factor for the Treatment of Retinal Degenerative Diseases |
10/21/2010 | US20100267642 Use of complex forms of calmodulin-like skin protein clsp |
10/21/2010 | US20100267641 Prognostic tests for development of dermal stretch marks and implications for the preventative treatment thereof |
10/21/2010 | US20100267617 Methods and compositions for mycoplasma pneumoniae exotoxins |
10/21/2010 | US20100267609 Compounds which inhibit beta-secretase activity and methods of use thereof |
10/21/2010 | US20100267596 Method for improving the hydrolysis stability of ionic liquids |
10/21/2010 | US20100267586 siRNA targeting KRAS |
10/21/2010 | US20100267585 Chemical ligation dependent probe amplification (CLPA) |
10/21/2010 | US20100267577 Methods for high throughput and quantitative proteome analysis |
10/21/2010 | US20100267569 Compositions, methods and kits for the diagnosis of carriers of mutations in the BRCA1 and BRCA2 genes and early diagnosis of cancerous disorders associated with mutations in BRCA1 and BRCA2 genes |
10/21/2010 | US20100267300 Method for producing reactive cyclodextrins textile material provided with same, and use of said cyclodextrin derivatives |
10/21/2010 | US20100267170 Robust, self-assembled, biocompatible films |
10/21/2010 | US20100267169 Electromagnetic molecular sensors and methods of using same |
10/21/2010 | US20100267168 Method for end titre determination and the evaluation thereof by means of an indirect immunoflurescence assay |
10/21/2010 | US20100267167 Device for detection of molecules in biological fluids |
10/21/2010 | US20100267166 Diagnostic detection device |
10/21/2010 | US20100267165 Microelectronic sensor device for the detection of target particles |
10/21/2010 | US20100267159 Simultaneous analysis of chlorides and sulfides by low pressure ion exclusion chromatography |
10/21/2010 | US20100267158 Electronic Detectors Inside Nanofluidic Channels For Detection, Analysis, and Manipulation of Molecules, Small Particles, and Small Samples of Material |
10/21/2010 | US20100267151 Misfolded protein sensor method |
10/21/2010 | US20100267150 Hdm2 polypeptides |
10/21/2010 | US20100267149 Methods of determining potency of chemically-synthesized oligonucleotides |
10/21/2010 | US20100267148 Method for the determination of the position of unsaturation in a compound |
10/21/2010 | US20100267138 Compositions and methods comprising a ligand of chemerinr |
10/21/2010 | US20100267092 Components |
10/21/2010 | US20100267077 method of measuring the ability of a sample to withstand reactive oxygen species (ross) |
10/21/2010 | US20100267071 Solution phase homogeneous assays |
10/21/2010 | US20100267069 Analysis of proteins from biological fluids using mass spectrometric immunoassay |
10/21/2010 | US20100267068 Analysis of doping compounds |
10/21/2010 | US20100267065 Apparatus and methods for analyzing fluid variables |
10/21/2010 | US20100267064 Methods for quantitative target detection and related devices and systems |
10/21/2010 | US20100267063 Methods and apparatuses for conducting assays |
10/21/2010 | US20100267062 Osteopontin as Novel Prognostic Biomarker for Heart Failure |
10/21/2010 | US20100267061 Detecting phospholipidosis and diagnosing lysosomal storage disorders |
10/21/2010 | US20100267060 High sensitivity secretagogin assays and their uses for diagnosis and/or prognosis |